FindTrial
Sign In

Studying the pain relieving properties of Angustura Vera medicine in patients with rheumatic disorders.

To Study the analgesic Effect of Angustura Vera in the Cases Of Rheumatic Disorders. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/058022
Enrollment
40
Registered
2023-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Angustura Vera: 30 potency, orally, twice a day, follow up every 15 days and S.O.S, total duration of 3 months. Control Intervention1: not applicable: not applicable

Sponsors

Dr Shalini Bali
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both Pre-diagnosed and newly diagnosed cases. Minimum 6 Follow ups.

Exclusion criteria

Exclusion criteria: Patients suffering from other severe systemic diseases. Advanced and irreversible pathological cases which require immediate medical attention. Patients with irregular follow ups. Rheumatic disorders in pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Pain relief in patients of rheumatic disordersTimepoint: 15 days after taking Angustura Vera—

Secondary

MeasureTime frame
To study the efficiency of Angustura Vera in pain management in cases of rheumatic disorders.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDr Shalini Bali

Jawaharlal Nehru Homoeopathic Medical College

jnhmc@paruluniversity.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026